Skip to content
ClinCalc Pro
Menu
Ocular lubricant (HA + osmoprotectant)

Sodium hyaluronate with trehalose

Brand names: Thealoz Duo

Sodium hyaluronate with trehalose is a preservative-free lubricant (artificial tear) eye drop used to relieve the symptoms of dry eye disease, combining a viscoelastic humectant with an osmoprotectant.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Sodium hyaluronate retains water and provides a long-residence lubricating film over the ocular surface, while trehalose acts as a bio-protective osmolyte that helps stabilise surface cells against desiccation and hyperosmolar stress.

Prescribing in practice

  • It provides symptomatic ocular surface lubrication and does not treat an underlying cause such as blepharitis or infection, which should be managed separately if present.
  • Preservative-free preparations are preferred for frequent use or where preservative sensitivity is a concern.
  • If other eye drops are also used, separate the instillation times and apply the lubricant last to avoid washout.

Monitoring

No laboratory monitoring is needed; review symptom relief and frequency of use, escalating dry-eye management if control is inadequate.

Counselling the patient

  • Use as often as needed for comfort, including before activities such as screen use that worsen dryness.
  • Apply lubricating drops last if you are using other eye medicines, leaving a short gap between them.
  • Seek review if the eye becomes painful, very red or vision is affected, as this is more than simple dryness.

Evidence & guidelines

Hyaluronate-based lubricants, including hyaluronate-trehalose combinations, are an established symptomatic treatment for dry eye disease, with preservative-free options recommended for frequent dosing.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.